Today's challenges to de-risk and predict drug safety in human “mind-the-gap”
RJ Weaver, JP Valentin - Toxicological Sciences, 2019 - academic.oup.com
Current gaps in drug safety sciences can result from the inability (1) to identify hazard across
multiple target organs,(2) to predict and risk assess with certainty against drug safety …
multiple target organs,(2) to predict and risk assess with certainty against drug safety …
Mechanisms and in vitro models of drug-induced cholestasis
E Gijbels, V Vilas-Boas, N Deferm, L Devisscher… - Archives of …, 2019 - Springer
Cholestasis underlies one of the major manifestations of drug-induced liver injury. Drug-
induced cholestatic liver toxicity is a complex process, as it can be triggered by a variety of …
induced cholestatic liver toxicity is a complex process, as it can be triggered by a variety of …
In-depth proteome analysis highlights HepaRG cells as a versatile cell system surrogate for primary human hepatocytes
Of the hepatic cell lines developed for in vitro studies of hepatic functions as alternatives to
primary human hepatocytes, many have lost major liver-like functions, but not HepaRG cells …
primary human hepatocytes, many have lost major liver-like functions, but not HepaRG cells …
Exploration of the molecular basis of forsythia fruit in the prevention and treatment of cholestatic liver injury through network pharmacology and molecular docking
K Fu, Y Li, S Dai, Y Li - Nutrients, 2023 - mdpi.com
Forsythia fruit, edible fruit of Forsythia suspensa (Thunb.) Vahl, which has been found to be
effective in treating cholestasis. However, its key component for alleviating cholestasis has …
effective in treating cholestasis. However, its key component for alleviating cholestasis has …
Identification of flucloxacillin-haptenated HLA-B* 57: 01 ligands: evidence of antigen processing and presentation
Flucloxacillin is a β-lactam antibiotic associated with a high incidence of drug-induced liver
reactions. Although expression of human leukocyte antigen (HLA)-B* 57: 01 increases …
reactions. Although expression of human leukocyte antigen (HLA)-B* 57: 01 increases …
Endoplasmic reticulum stress precedes oxidative stress in antibiotic-induced cholestasis and cytotoxicity in human hepatocytes
A Burban, A Sharanek, C Guguen-Guillouzo… - Free Radical Biology …, 2018 - Elsevier
Endoplasmic reticulum (ER) stress has been associated with various drug–induced liver
lesions but its participation in drug-induced cholestasis remains unclear. We first aimed at …
lesions but its participation in drug-induced cholestasis remains unclear. We first aimed at …
Specific roles of HSP27 S15 phosphorylation augmenting the nuclear function of HER2 to promote trastuzumab resistance
SY Hwang, SK Choi, SH Seo, H Jo, JH Shin, Y Na… - Cancers, 2020 - mdpi.com
Trastuzumab (TZMB) is widely used as first line therapy for breast cancer (BC) patients
overexpressing human epidermal growth factor receptor 2 (HER2). Despite its clinical …
overexpressing human epidermal growth factor receptor 2 (HER2). Despite its clinical …
In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist
M Vinken - Archives of toxicology, 2018 - Springer
Cholestasis is derived from the Greek words chole meaning bile and stasis indicating halting
(Noor 2015), and denotes any situation of impaired bile secretion with concomitant …
(Noor 2015), and denotes any situation of impaired bile secretion with concomitant …
Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury
Flucloxacillin is a β-lactam antibiotic associated with a high incidence of drug-induced liver
injury. Although expression of HLA-B* 57: 01 is associated with increased susceptibility, little …
injury. Although expression of HLA-B* 57: 01 is associated with increased susceptibility, little …
Mechanisms of drug-induced cholestasis
E Gijbels, M Vinken - Experimental Cholestasis Research, 2019 - Springer
Cholestasis can be defined as any situation of impaired bile secretion with concomitant
accumulation of bile acids in the liver or in the systemic circulation. A variety of factors may …
accumulation of bile acids in the liver or in the systemic circulation. A variety of factors may …